Information:
Error:
ID
32713
Description
Study ID: 107038 Clinical Study ID: LPL107038 Study Title: Study to Estimate the Dose Proportionality of the Enteric-Coated Freebase Formulation of SB-480848 Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: Tyrisa ,US Study Indication: Atherosclerosis
Keywords
Versions (1)
- 11/13/18 11/13/18 -
Copyright Holder
GSK group of companies
Uploaded on
November 13, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Estimation of Dose Proportionality of Darapladib - 107038
PGx-Pharmacogenetic Research Consent
- StudyEvent: ODM
Similar models
PGx-Pharmacogenetic Research Consent
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
PGx-Pharmacogenetic Research Consent Question
Has Informed consent been obtained for PGx-Pharmacogenetic research?
Item
Has Informed consent been obtained for PGx-Pharmacogenetic research?
boolean
If YES, record Date informed consent obtained for PGx-Pharmacogenetic research
Item
If YES, record Date informed consent obtained for PGx-Pharmacogenetic research
date
CL Item
Subject declined (1)
CL Item
Subject not asked by Investigator (2)
CL Item
Other (3)
If OTHER, specify
Item
If OTHER, specify
text
Has a blood sample been collected for PGx-pharmacogenetic research?
Item
Has a blood sample been collected for PGx-pharmacogenetic research?
boolean
If YES, record date sample taken
Item
If YES, record date sample taken
boolean
No comments